GENE ONLINE|News &
Opinion
Blog

Progression Free Survival
Beigene’s Tislelizumab-Chemo Combo Nails Primary Endpoint in Phase 3 Trial
2020-04-16
Tecentriq/Arbaxane Combo Becomes the First FDA Approved Immunotherapy Regimen for Breast Cancer Treatment
2019-03-14
The ups and downs of Chi-Med’s Fruquintinib
2018-11-28
Pfizer’s Talzenna approved for breast cancer treatment
2018-10-25
M&A
Targeted cancer radiopharma specialist – ENDOCYTE INC.’s acquisition
2018-10-23
R&D
A new player emerges in the non-small cell lung cancer (NSCLC) therapy scene
2018-10-11
LATEST
The Impact of “Inner Excellence” on A.J. Brown’s Performance and Mindset
2025-01-14
Menarini Group and Insilico Medicine Enter a Second Exclusive Global License Agreement for an AI Discovered Preclinical Asset Targeting High Unmet Needs in Oncology
2025-01-10
United Imaging Announces Major Expansion of U.S. Manufacturing Space
2025-01-09
Posdinemab Becomes J&J’s Second FDA Fast Track Designation Targeting Phosphorylated Tau in Alzheimer’s Disease
2025-01-09
Key Market Trends Shaping Health Systems and Specialty Pharmacies
2025-01-08
COVID Caused Cancer Tumors to Shrink in Mice and We Want to Know How
2025-01-08
Catapulting Stem Cell Research into the Future: Innovation and Global Impact at ISSCR 2025 in Hong Kong
2025-01-08
EVENT
2025-01-13
Biotech Showcase 2025
San Francisco, California
2025-01-13
JP Morgan Healthcare Conference
San Francisco, California
2025-02-05
Precision Medicine World Conference 2025
Santa Clara, California
2025-02-19
Healthcare Conference Taipei 2025
Taipei, Taiwan
2025-03-17
BIO-Europe Spring 2025
Milan, Italy
Scroll to Top